Temporal Changes of the Oral and Fecal Microbiota after Mild Traumatic Brain Injury in Rats by 16S rRNA Sequencing

Shujuan Wang1, Yanjie Shang1, Zhiyun Pi1

  • 1Department of Forensic Science, School of Basic Medical Sciences, Central South University, Changsha 410013, China.

Microorganisms
|June 28, 2023
PubMed

Insights

Mild traumatic brain injury (mTBI) alters gut and oral bacteria, offering potential biomarkers for mTBI identification and time estimation. Specific bacterial families like Fusobacteria may aid in diagnosis.

Area of Science:

  • Microbiome Research
  • Neuroscience
  • Forensic Science

Background:

  • Mild traumatic brain injury (mTBI) poses risks for neurodegenerative diseases, with long-term consequences often underestimated.
  • The gut-brain axis, involving oral and fecal microbiota, is increasingly recognized for its role in brain injury.
  • Accurate mTBI identification is crucial in forensic science for case evidence.

Purpose of the Study:

  • To investigate the relationship between temporal changes in oral and fecal bacterial communities and mTBI.
  • To explore the potential of microbiota for mTBI damage identification and post-injury time estimation.

Main Methods:

  • 16S rRNA sequencing was used to analyze oral and fecal bacterial communities in mTBI rats.
  • Samples were collected at 12 different time points post-injury (from 0 h to 14 d) and compared to a sham group.
  • Analysis focused on changes in bacterial community structure and abundance.

Main Results:

  • Significant variations in bacterial community abundance were observed in mTBI rats compared to controls.
  • Fusobacteria, Prevotellaceae, Ruminococcaceae, and Lactobacillaceae were identified as potential biomarkers for mTBI identification.
  • Two hours post-injury emerged as a critical time point for estimating injury duration based on microbiota changes.

Conclusions:

  • Oral and fecal microbiota composition changes dynamically after mTBI, offering diagnostic potential.
  • Specific bacterial taxa may serve as reliable indicators for mTBI identification and temporal assessment.
  • Findings suggest novel therapeutic avenues targeting the gut-brain axis for mTBI management.